Assessment of Skin and Mucosal Changes During Acute Illness and Remission of Covid-19 Patients
Keywords:
COVID-19, skin, mucous membranes, rashes
Abstract
Our tests were performed on 104 COVID-19 patients between the ages of 2 and 75. The diagnosis of COVID-19 has been confirmed based on clinical, epidemiological and laboratory findings.
The patients studied were mainly those who had the disease in May-June 2021, and their age was as follows: 1 person 1 year, 2 people 3 years, 1 person 6 years old, 1 person 11 years old, 1 person 17 years old, 1 person 19 years old, 1 person 22 years old, 9 people 24 years old, 19 people 30-34 years old, 6 people 39 years old, 6 people 40-44 years old, 3 people 45-49 years old, 8 people 50-55 years old, 11 people 55- 59 years old, 10 people 60-64 years old, 16 people 65-69 years old, 11 people over 70 years old.
References
1. Hafeez A, Ahmad S, Siddqui SA, Ahmad M, Mishra S. A review of COVID-19 (Coronavirus Disease-2019) diagnosis, treatments and prevention. Eurasian Journal of Medicine and Oncology 2020; 4(2):116-125. doi:10.14744/ejmo.2020.90853
2. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Bio-medica: AteneiParmensis 2020; 91(1):157-160. doi:10.23750/abm.v91i1.9397
3. Zhao N, Zhou ZL, Wu L, Zhang XD, Han SB et al. An update on the status of COVID-19: a comprehensive review. European Review for Medical and Pharmacological Sciences 2020; 24(8):4597-4606. doi:10.26355/eurrev_202004_21046
4. Rakhmatov, O. B. (2021). IMPROVING THE PRINCIPLES OF TREATMENT IN PATIENTS WITH ZOONOTIC LEISHMANIASIS WITH THE IMMUNOMODULATOR GEPON AND METHYLENE BLUE USING THE ALT-VOSTOK DEVICE. 湖南大学学报 (自然科学版), 48(9).
5. Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung SM et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). International Journal of Infectious Diseases 2020; 94: 154-155. doi:10.1016/j.ijid.2020.03.020
6. Hu Z, Song C, Xu C, Jin G, Chen Y et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Science China. Life Sciences 2020; 63 (5): 706-711. doi:10.1007/s11427-020-1661- 4
7. Rakhmatov, O. B. (2021). IMPROVING THE PRINCIPLES OF TREATMENT IN PATIENTS WITH ZOONOTIC LEISHMANIASIS WITH THE IMMUNOMODULATOR GEPON AND METHYLENE BLUE USING THE ALT-VOSTOK DEVICE. 湖南大学学报 (自然科学版), 48(9).
8. Dong X, Cao YY, Lu XX, Zhang JJ, Du H et al. Eleven faces of coronavirus disease 2019. Allergy 2020; 10.1111/all.14289. doi:10.1111/all.14289 . Ai T, Yang Z, Hou H, Zhan C, Chen C et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology 2020: 200642. doi:10.1148/radiol.2020200642
9. Galván Casas C, Català A, Carretero Hernández G, RodríguezJiménez P, Fernández Nieto D et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. British Journal of Dermatology 2020. doi:10.1111/bjd.19163
10. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. Journal of the European Academy of Dermatology and Venereology 2020. doi:10.1111/jdv.16387
11. Estébanez A, Pérez-Santiago L, Silva E, Guillen-Climent S, García-Vázquez A, Ramón M. Cutaneous manifestations in COVID-19: a new contribution. Journal of the European Academy of Dermatology and Venereology 2020. doi:10.1111/ jdv.16474
12. Fernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, Suarez-Valle A, Moreno-Arrones OM, Saceda-Corralo D et al. Characterization of acute acro-ischemic lesions in nonhospitalized patients: a case series of 132 patients during the COVID-19 outbreak. Journal of the American Academy of Dermatology 2020. doi:10.1016/j.jaad.2020.04.093 M
13. Mungmungpuntipantip R, Wiwanitkit V. COVID-19 and cutaneous manifestations. Journal of the European Academy of Dermatology and Venereology 2020. doi:10.1111/jdv.16483
14. Sachdeva M, Gianotti R, Shah M, Lucia B, Tosi T et al. Cutaneous manifestation
2. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Bio-medica: AteneiParmensis 2020; 91(1):157-160. doi:10.23750/abm.v91i1.9397
3. Zhao N, Zhou ZL, Wu L, Zhang XD, Han SB et al. An update on the status of COVID-19: a comprehensive review. European Review for Medical and Pharmacological Sciences 2020; 24(8):4597-4606. doi:10.26355/eurrev_202004_21046
4. Rakhmatov, O. B. (2021). IMPROVING THE PRINCIPLES OF TREATMENT IN PATIENTS WITH ZOONOTIC LEISHMANIASIS WITH THE IMMUNOMODULATOR GEPON AND METHYLENE BLUE USING THE ALT-VOSTOK DEVICE. 湖南大学学报 (自然科学版), 48(9).
5. Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung SM et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). International Journal of Infectious Diseases 2020; 94: 154-155. doi:10.1016/j.ijid.2020.03.020
6. Hu Z, Song C, Xu C, Jin G, Chen Y et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Science China. Life Sciences 2020; 63 (5): 706-711. doi:10.1007/s11427-020-1661- 4
7. Rakhmatov, O. B. (2021). IMPROVING THE PRINCIPLES OF TREATMENT IN PATIENTS WITH ZOONOTIC LEISHMANIASIS WITH THE IMMUNOMODULATOR GEPON AND METHYLENE BLUE USING THE ALT-VOSTOK DEVICE. 湖南大学学报 (自然科学版), 48(9).
8. Dong X, Cao YY, Lu XX, Zhang JJ, Du H et al. Eleven faces of coronavirus disease 2019. Allergy 2020; 10.1111/all.14289. doi:10.1111/all.14289 . Ai T, Yang Z, Hou H, Zhan C, Chen C et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology 2020: 200642. doi:10.1148/radiol.2020200642
9. Galván Casas C, Català A, Carretero Hernández G, RodríguezJiménez P, Fernández Nieto D et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. British Journal of Dermatology 2020. doi:10.1111/bjd.19163
10. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. Journal of the European Academy of Dermatology and Venereology 2020. doi:10.1111/jdv.16387
11. Estébanez A, Pérez-Santiago L, Silva E, Guillen-Climent S, García-Vázquez A, Ramón M. Cutaneous manifestations in COVID-19: a new contribution. Journal of the European Academy of Dermatology and Venereology 2020. doi:10.1111/ jdv.16474
12. Fernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, Suarez-Valle A, Moreno-Arrones OM, Saceda-Corralo D et al. Characterization of acute acro-ischemic lesions in nonhospitalized patients: a case series of 132 patients during the COVID-19 outbreak. Journal of the American Academy of Dermatology 2020. doi:10.1016/j.jaad.2020.04.093 M
13. Mungmungpuntipantip R, Wiwanitkit V. COVID-19 and cutaneous manifestations. Journal of the European Academy of Dermatology and Venereology 2020. doi:10.1111/jdv.16483
14. Sachdeva M, Gianotti R, Shah M, Lucia B, Tosi T et al. Cutaneous manifestation
Published
2021-10-30
How to Cite
Xushvaqtova, M. F., & Raxmatov , O. B. (2021). Assessment of Skin and Mucosal Changes During Acute Illness and Remission of Covid-19 Patients. Central Asian Journal of Medical and Natural Science, 288-291. https://doi.org/10.17605/cajmns.vi0.428
Section
Articles
